Safety of apixaban in Indian patients undergoing elective total knee replacement or total hip replacement surgery: A multi-center, phase-IV study

Background: Venous thromboembolism is a significant source of morbidity and mortality following total hip replacement and total knee replacement. Apixaban has been proven to be efficacious without increased risk of bleeding in phase-III trials in patients undergoing total knee replacement and total...

Full description

Bibliographic Details
Main Authors: Himanshu Panchal, Abhijit Agashe, Parag K Sancheti, Namrata B Kulkarni, Santosh R Taur
Format: Article
Language:English
Published: SAGE Publishing 2021-10-01
Series:SAGE Open Medicine
Online Access:https://doi.org/10.1177/20503121211049962